Andrea K. Mccollum

Array ( [id] => 8964359 [patent_doc_number] => 20130203961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen' [patent_app_type] => utility [patent_app_number] => 13/463250 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22684 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11635151 [patent_doc_number] => 09657110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-23 [patent_title] => 'Polypeptides and use thereof' [patent_app_type] => utility [patent_app_number] => 14/113827 [patent_app_country] => US [patent_app_date] => 2012-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28263 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11773451 [patent_doc_number] => 09382290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Aptamer-modified polymeric materials for the binding of factors in a wound environment' [patent_app_type] => utility [patent_app_number] => 13/458071 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22262 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338382 [patent_doc_number] => 20140065164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'IP-10 ANTIBODY DOSAGE ESCALATION REGIMENS' [patent_app_type] => utility [patent_app_number] => 14/114652 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22315 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12113685 [patent_doc_number] => 09869673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Diagnostic markers and therapeutic targets of kawasaki disease' [patent_app_type] => utility [patent_app_number] => 14/111816 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 12584 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442475 [patent_doc_number] => 20120259092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'NPY ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/444675 [patent_app_country] => US [patent_app_date] => 2012-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4415 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13444675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9331055 [patent_doc_number] => 20140057838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'OSTEOBLAST-EXPRESSED LIPOCALIN 2 REGULATES GLUCOSE METABOLISM' [patent_app_type] => utility [patent_app_number] => 14/111324 [patent_app_country] => US [patent_app_date] => 2012-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 26349 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9318759 [patent_doc_number] => 20140051097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'METHODS FOR DETECTING CONTAMINANTS IN SOLUTIONS CONTAINING GLUCOSE POLYMERS' [patent_app_type] => utility [patent_app_number] => 14/110569 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16367 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9462808 [patent_doc_number] => 20140127235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'TARGETING HK alpha FOR CONTROLLING BLOOD PRESSURE AND REGULATING ELECTROLYTE BALANCE' [patent_app_type] => utility [patent_app_number] => 14/110197 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24992 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441509 [patent_doc_number] => 20120258117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Methods and compositions for modulation of histone ubiquitination' [patent_app_type] => utility [patent_app_number] => 13/440510 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8556 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16878016 [patent_doc_number] => 11028149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => Recombinant polypeptide production method [patent_app_type] => utility [patent_app_number] => 14/008791 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 29 [patent_no_of_words] => 13631 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9397182 [patent_doc_number] => 20140094588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'PROGNOSTIC AND THERAPEUTIC SIGNATURE FOR MALIGNANT MELANOMA' [patent_app_type] => utility [patent_app_number] => 14/008222 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22767 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10174943 [patent_doc_number] => 09205131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Use of IL-17D for the treatment and prevention of cancers' [patent_app_type] => utility [patent_app_number] => 14/004421 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17429 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11886922 [patent_doc_number] => 09757469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Pharmaceutical preparation' [patent_app_type] => utility [patent_app_number] => 14/008067 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 13056 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222927 [patent_doc_number] => 20140017702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'BIOMARKERS FOR ACUTE KIDNEY INJURY' [patent_app_type] => utility [patent_app_number] => 14/006991 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13593 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11886922 [patent_doc_number] => 09757469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Pharmaceutical preparation' [patent_app_type] => utility [patent_app_number] => 14/008067 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 13056 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732678 [patent_doc_number] => 20130078247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'BISPECIFIC BINDING MOLECULES BINDING TO DII4 AND ANG2' [patent_app_type] => utility [patent_app_number] => 13/433354 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 34996 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601260 [patent_doc_number] => 09321813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Methods and compositions for cytomegalovirus IL-10 protein' [patent_app_type] => utility [patent_app_number] => 14/008484 [patent_app_country] => US [patent_app_date] => 2012-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 47047 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602643 [patent_doc_number] => 20140199324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'EVALUATING PROTEIN EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCER' [patent_app_type] => utility [patent_app_number] => 14/007102 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25662 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11211988 [patent_doc_number] => 09441017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Water-soluble polypeptides comprised of repeat modules, method for preparing the same and method for a target-specific polypeptide and analysis of biological activity thereof' [patent_app_type] => utility [patent_app_number] => 14/005536 [patent_app_country] => US [patent_app_date] => 2012-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 16967 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005536 [rel_patent_id] =>[rel_patent_doc_number] =>)